Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.7%

1 terminated out of 37 trials

Success Rate

91.7%

+5.1% vs benchmark

Late-Stage Pipeline

11%

4 trials in Phase 3/4

Results Transparency

27%

3 of 11 completed with results

Key Signals

3 with results92% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (19)
P 2 (1)
P 3 (1)
P 4 (3)

Trial Status

Completed11
Not Yet Recruiting8
Recruiting7
Unknown7
Enrolling By Invitation1
Terminated1

Trial Success Rate

91.7%

Benchmark: 86.6%

Based on 11 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT07628270RecruitingPrimary

Insights From the FAST-TRACK CABG Trial: a Clinical Outcome Study in Patient With Previous Surgical Revascularization for Complex Three-vessel or Left Main Coronary Artery Disease Based on Coronary Computed Tomography Angiogram, and Fractional Flow Reserve Derived by Computed Tomography

NCT01311323Not ApplicableRecruitingPrimary

Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease

NCT05333068Not ApplicableActive Not RecruitingPrimary

COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events

NCT07602790Not ApplicableNot Yet RecruitingPrimary

Expand Management of Blood Pressure With Renal Denervation in Patients Undergoing Staged PCI for Advanced Coronary Artery diseasE

NCT07598565Not ApplicableNot Yet Recruiting

The CORE - μFR Clinical Trial

NCT07269366Not ApplicableRecruiting

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)

NCT07491107Not Yet Recruiting

Brazilian Prospective Registry of the Inspiron EVO Drug-Eluting Stent in Complex Coronary Lesions

NCT06740552CompletedPrimary

Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

NCT07362108Completed

Cardiovascular Events Related to Treated Coronary Arteries in Stable Multivessel CAD

NCT07264881Not Yet Recruiting

For Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure, Avoiding a Return Hospital Visit for a Second Operation.

NCT06168305Enrolling By Invitation

Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease

NCT01881555Not ApplicableCompletedPrimary

Functional Testing Underlying Coronary Revascularisation

NCT07149714Not ApplicableRecruiting

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI

NCT07133984Recruiting

STICH3C Cardiac Magnetic Resonance Observational Study

NCT06400290Not ApplicableRecruiting

Multivessel Balloon Occlusion to Investigate Obstructive Coronary Artery Disease and aNgina

NCT06928883Not ApplicableNot Yet Recruiting

Ticin Pilot Study: Sirolimus-Eluting Balloon for Stabilization and Regression of Non-Obstructive Coronary Plaques.

NCT05786131Not ApplicableRecruiting

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI

NCT06378775Not ApplicableNot Yet Recruiting

Robotically-assisted Minimally-invasive Direct Coronary Artery Bypass With Stenting, Randomized Against Coronary Artery Bypass Graft Surgery

NCT05669222Not ApplicableNot Yet Recruiting

The FAVOR V AMI Trial

NCT06025071Phase 4Unknown

Residual Inflammatory Risk-Guided colcHicine in Elderly Trial

Scroll to load more

Research Network

Activity Timeline